Genomic instabilities in hepatocellular carcinoma: biomarkers and application in immunotherapies
Jui-Hsiang Hunga,1, Chiao-Feng Tengb,c,d,e,1, Hsu-chin Hungh, Yi-Lin Chenf, Pin-Jun Cheng, Chung-Liang Hof,g,h, Cheng-Hsiang Chuangi, Wenya Huangf,h,j,k,
Corresponding author
a Department of Biotechnology, Chia Nan University of Pharmacy & Science, Tainan, Taiwan
b Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan
c Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan
d Program for Cancer Biology and Drug Development, China Medical University, Taichung, Taiwan
e Research Center for Cancer Biology, China Medical University, Taichung, Taiwan
f Department of Pathology, National Cheng Kung University Hospital, Tainan, Taiwan
g Institute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
h Institute of Basic Medical Science, College of Medicine, National Cheng Kung University, Tainan, Taiwan
i Department of Life Science, College of Life Sciences and Medicine, National Tsing Hua University, Hsinchu, Taiwan
j Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan
k Center of Infectious Diseases and Signal Transduction, National Cheng Kung University, Tainan, Taiwan.
Ver más
